tirzepatide for iih Efficacy of Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study Lilly's Tirzepatide Reduced Heart Failure
Description
Halloum W, Dughem YA, Beier D, Pellesi L (2024) Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review
This holistic approach ensures that all aspects of your physical well-being are supported by qualified medical professionals
Skin hyperesthesia: An unusual side effect reported in some trial participants, this involves increased skin sensitivity or unusual sensations
It did not increase cardiovascular mortality, there were no new ischemic events, and no signals of arrhythmogenicity were detected during patient followup [72]
